Blog

State’s stem cell agency awards $18.2 million grant for B cell cancer clinical trial – EurekAlert (press release)


EurekAlert (press release)

State's stem cell agency awards $18.2 million grant for B cell cancer clinical trial
EurekAlert (press release)
Kipps noted, too that cirmtuzumab targets cancer stem cells, which behave somewhat like the roots of the disease, resisting many forms of treatment and allowing a malignancy to grow back after apparently successful therapy. By targeting cancer stem

2017-08-24 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.